Organisation paid for research Program year 2020 Source: CMS Open Payments

US Oncology Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$341,558

92 payments

Through program year 2020, US Oncology Research Inc. is reported as receiving $341,558 in research payments, across 92 payments.

By program year

1 row
Year Kind Amount Payments
2020 Research $341,558 92

Breakdown

Who paid Research payments · program year 2020
  1. F. Hoffmann-La Roche AG $215,560 39 payments
  2. Pharmacyclics LLC, An AbbVie Company $89,040 43 payments
  3. Genentech, Inc. $36,958 10 payments
Studies the money was for Research payments · program year 2020
  1. 1L Nsclc DX All Comer Non Squamous $214,480 38 payments
  2. Pcyc-1141-Ca $89,040 43 payments
  3. PH II Placebo Controlled of Mtig7192a and Atezo in Nsclc $36,958 10 payments
  4. 1L Nsclc DX All Comer Squamous $1,080 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record